Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

228
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
228
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

305
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
305
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

520
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
520
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

477
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
477
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

427
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
427
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

215
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
215

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence and Management of Access Site Infection Following Trans-Axillary Implant of a Microaxial Left Ventricular Assist Device.

Artificial organs·2026
Same author

Updates in the Treatment of Pediatric Pulmonary Arterial Hypertension.

Cardiology in review·2026
Same author

Probable recurrence of cardiac sarcoidosis in a transplanted heart.

JHLT open·2025
Same author

Sotatercept: A New Era in Pulmonary Arterial Hypertension.

Cardiology in review·2025
Same author

Ethical and Technical Challenges in the Removal of Temporary Left Ventricular Assist Device in Patients With Advanced Heart Failure: A Multidisciplinary Approach.

Journal of cardiac failure·2024
Same author

Axillary artery access considerations in Impella 5.5 insertion: Insights from exclusive axillary approach for successful support.

Artificial organs·2024
Same journal

Beta-Blockers Versus Flecainide for Atrial Fibrillation: A First-Line Strategy Review of Efficacy, Safety, and Patient Selection.

Cardiology in review·2026
Same journal

Cerebrovascular Disease in Pregnancy: Epidemiology, Pathophysiology, Risk Factors, Diagnostic and Management Considerations, Long-Term Maternal Outcomes: A Narrative Review.

Cardiology in review·2026
Same journal

Immunometabolism in Cardiovascular Disease: Linking Metabolic Reprogramming to Inflammation, Atherothrombosis, and Clinical Outcomes.

Cardiology in review·2026
Same journal

Cardiotoxicity of Antibody-Drug Conjugates in HER2-Positive Cancer: Beyond Left Ventricular Ejection Fraction Decline.

Cardiology in review·2026
Same journal

Celiac Disease and Cardiovascular Disease: Epidemiology, Mechanisms, and Clinical Challenges.

Cardiology in review·2026
Same journal

Valve-Specific Comparative Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists After Surgical Valve Procedures in Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Cardiology in review·2026
See all related articles

Related Experiment Video

Updated: Jan 6, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.8K

Third-Generation LVADs: Has Anything Changed?

Avi Levine1, Alan Gass

  • 1From the Division of Cardiology, Department of Medicine, New York Medical College/Westchester Medical Center, Valhalla, NY.

Cardiology in Review
|October 5, 2019
PubMed
Summary
This summary is machine-generated.

Durable left ventricular assist devices have evolved significantly from pulsatile to continuous flow technologies. This review examines the technological advancements and their impact on patient care.

More Related Videos

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.2K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.0K

Related Experiment Videos

Last Updated: Jan 6, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.8K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.2K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.0K

Area of Science:

  • Cardiovascular Engineering
  • Medical Device Technology
  • Cardiac Surgery

Background:

  • Left ventricular assist devices (LVADs) are critical for end-stage heart failure management.
  • Technological progress has transformed LVADs from early pulsatile devices to modern continuous flow systems.
  • Continuous innovation aims to improve device longevity, efficacy, and patient quality of life.

Purpose of the Study:

  • To review the technological evolution of durable left ventricular assist devices.
  • To analyze the changes in LVAD technology over time.
  • To critically assess the impact of these advancements.

Main Methods:

  • Literature review of historical and current LVAD technologies.
  • Analysis of device generations: first-generation pulsatile (e.g., HeartMate XVE), second-generation axial flow (e.g., HeartMate-2), and third-generation centrifugal flow devices.
  • Examination of key technological shifts and their clinical implications.

Main Results:

  • Significant advancements in pump design, from pulsatile to continuous flow.
  • Introduction of axial and centrifugal flow technologies improving device profiles and durability.
  • Enhanced biocompatibility and reduced adverse event rates with newer generations.
  • The fundamental question of change is answered affirmatively through technological progression.

Conclusions:

  • Left ventricular assist device technology has undergone substantial evolution.
  • Continuous flow devices represent a major leap forward from earlier pulsatile models.
  • Ongoing innovation continues to refine LVAD therapy for heart failure patients.